The mitochondria: A target of polyphenols in the treatment of diabetic cardiomyopathy
المؤلف | Bhagani, Humna |
المؤلف | Nasser, Suzanne A. |
المؤلف | Dakroub, Ali |
المؤلف | El-Yazbi, Ahmed F. |
المؤلف | Eid, Assaad A. |
المؤلف | Kobeissy, Firas |
المؤلف | Pintus, Gianfranco |
المؤلف | Eid, Ali H. |
تاريخ الإتاحة | 2023-09-25T10:26:16Z |
تاريخ النشر | 2020 |
اسم المنشور | International Journal of Molecular Sciences |
المصدر | Scopus |
الملخص | Diabetic cardiomyopathy (DCM) is a constellation of symptoms consisting of ventricular dysfunction and cardiomyocyte disarray in the presence of diabetes. The exact cause of this type of cardiomyopathy is still unknown; however, several processes involving the mitochondria, such as lipid and glucose metabolism, reactive oxygen species (ROS) production, apoptosis, autophagy and mitochondrial biogenesis have been implicated. In addition, polyphenols have been shown to improve the progression of diabetes. In this review, we discuss some of the mechanisms by which polyphenols, particularly resveratrol, play a role in slowing the progression of DCM. The most important intermediates by which polyphenols exert their protective effect include Bcl-2, UCP2, SIRT-1, AMPK and JNK1. Bcl-2 acts to attenuate apoptosis, UCP2 decreases oxidative stress, SIRT-1 increases mitochondrial biogenesis and decreases oxidative stress, AMPK increases autophagy, and JNK1 decreases apoptosis and increases autophagy. Our dissection of these molecular players aims to provide potential therapeutic targets for the treatment of DCM. |
راعي المشروع | Funding: This work has been made possible by (UNISS fondo di ateneo per la ricerca 2019) grant to G.P., and an MPP 320133 fund from the American University of Beirut (AHE). |
اللغة | en |
الناشر | MDPI |
الموضوع | Autophagy Diabetic cardiomyopathy Polyphenols Resveratrol |
النوع | Article |
الصفحات | 1-12 |
رقم العدد | 14 |
رقم المجلد | 21 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
العلوم الحيوية الطبية [697 items ]